Literature DB >> 16319024

Global brain atrophy and corticospinal tract alterations in ALS, as investigated by voxel-based morphometry of 3-D MRI.

Jan Kassubek1, Alexander Unrath, Hans-Jürgen Huppertz, Dorothée Lulé, Thomas Ethofer, Anne-Dorte Sperfeld, Albert C Ludolph.   

Abstract

In ALS, advanced magnetic resonance imaging (MRI) techniques are increasingly used to investigate the underlying pathology. In this study, the technique of voxel-based morphometry (VBM) was applied to 3-D MRI data in ALS patients to localize regional grey and white matter changes. Twenty-two ALS patients (mean age 58+/-9 years) with clinically definite ALS by revised El Escorial criteria were studied. None of the patients had any signs of associated frontotemporal dementia. High-resolution 3-D MRI data sets of the whole brain, collected on a 1.5 T scanner, were analysed by statistical parametric mapping (SPM) and VBM in comparison to an age-matched normal data base consisting of 22 healthy volunteers (mean age 59+/-11 years), for grey matter and white matter segments separately. Global brain atrophy was assessed by calculation of brain parenchymal fractions (BPF). In ALS patients, BPF were significantly reduced compared to controls (p = 0.0003), indicating global brain atrophy. Regional decreases of grey matter density were found in the ALS patients at corrected p<0.01 in the right-hemispheric primary motor cortex (area of the highest Z-score) and in the left medial frontal gyrus. Furthermore, regional white matter alterations were observed along the corticospinal tracts bilaterally and in multiple smaller areas including corpus callosum, cerebellum, frontal and occipital subcortical regions. Besides considerable global atrophy in ALS, the topography of ALS-associated cerebral morphological changes could be mapped using VBM, in particular white matter signal changes along the bilateral corticospinal tracts, but also in extra-motor areas. VBM might be a potential tool to visualize disease progression in future longitudinal studies.

Entities:  

Mesh:

Year:  2005        PMID: 16319024     DOI: 10.1080/14660820510038538

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord        ISSN: 1466-0822


  66 in total

Review 1.  Neuroimaging in amyotrophic lateral sclerosis.

Authors:  Sumei Wang; Elias R Melhem; Harish Poptani; John H Woo
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

2.  Advances in the application of MRI to amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Michel Modo
Journal:  Expert Opin Med Diagn       Date:  2010-11

3.  Neuroimaging of motor neuron diseases.

Authors:  Jan Kassubek; Albert C Ludolph; Hans-Peter Müller
Journal:  Ther Adv Neurol Disord       Date:  2012-03       Impact factor: 6.570

Review 4.  The present and the future of neuroimaging in amyotrophic lateral sclerosis.

Authors:  F Agosta; A Chiò; M Cosottini; N De Stefano; A Falini; M Mascalchi; M A Rocca; V Silani; G Tedeschi; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-01       Impact factor: 3.825

Review 5.  Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants.

Authors:  Shahram Saberi; Jennifer E Stauffer; Derek J Schulte; John Ravits
Journal:  Neurol Clin       Date:  2015-11       Impact factor: 3.806

6.  Computer-based 3D MR imaging analysis in amyotrophic lateral sclerosis: common and specific factors among studies.

Authors:  A Unrath; J Kassubek
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-20       Impact factor: 3.825

7.  Neurodegenerative diseases target large-scale human brain networks.

Authors:  William W Seeley; Richard K Crawford; Juan Zhou; Bruce L Miller; Michael D Greicius
Journal:  Neuron       Date:  2009-04-16       Impact factor: 17.173

8.  In vivo voxel-based relaxometry in amyotrophic lateral sclerosis.

Authors:  Martina Minnerop; Karsten Specht; Jürgen Ruhlmann; Christoph Grothe; Ullrich Wüllner; Thomas Klockgether
Journal:  J Neurol       Date:  2009-02-16       Impact factor: 4.849

9.  Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis.

Authors:  N Filippini; G Douaud; C E Mackay; S Knight; K Talbot; M R Turner
Journal:  Neurology       Date:  2010-11-02       Impact factor: 9.910

10.  Corpus callosum area in amyotrophic lateral sclerosis.

Authors:  Molly C Chapman; Laura Jelsone-Swain; Brett W Fling; Timothy D Johnson; Kirsten Gruis; Robert C Welsh
Journal:  Amyotroph Lateral Scler       Date:  2012-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.